PMV Pharmaceuticals, Inc.
PMVP
Price:
$1.61
Market Cap:
$83.31M
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.[Read more]
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
PMVP
PE Ratio
[-1.61]
ROE
[-24.20%]
Current Ratio
[13.98]
Dividend Yield
[0%]
Enterprise Value
[47.77M]
Dividend History
The ROE as of November 2024 (TTM) for PMV Pharmaceuticals, Inc. (PMVP) is -24.20%
According to PMV Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -24.20%. This represents a change of 296.08% compared to the average of -6.11% of the last 4 quarters.
PMV Pharmaceuticals, Inc. (PMVP) Historical ROE (quarterly & annually)
How has PMVP ROE performed in the past?
The mean historical ROE of PMV Pharmaceuticals, Inc. over the last ten years is -2.45%. The current -24.20% ROE has changed 887.24% with respect to the historical average. Over the past ten years (40 quarters), PMVP's ROE was at its highest in in the December 2019 quarter at 10.00%. The ROE was at its lowest in in the March 2019 quarter at -9.91%.
Average
-2.45%
Median
-14.17%
Minimum
-30.56%
Maximum
38.01%
PMV Pharmaceuticals, Inc. (PMVP) ROE by Quarter and Year
Discovering the peaks and valleys of PMV Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.48%
Maximum Annual ROE = 38.01%
Minimum Annual Increase = -126.66%
Minimum Annual ROE = -30.56%
| Year | ROE | Change |
|---|---|---|
| 2023 | -30.56% | 2.53% |
| 2022 | -29.80% | 58.96% |
| 2021 | -18.75% | 95.48% |
| 2020 | -9.59% | -126.66% |
| 2019 | 35.97% | -5.36% |
PMV Pharmaceuticals, Inc. (PMVP) Average ROE
How has PMVP ROE performed in the past?
The current ROE of PMV Pharmaceuticals, Inc. (PMVP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-26.37%
5-year avg
-10.54%
10-year avg
-2.45%
PMV Pharmaceuticals, Inc. (PMVP) ROE vs. Peers
How is PMVP’s ROE compared to its peers?
PMV Pharmaceuticals, Inc.’s ROE is greater than Eliem Therapeutics, Inc. (-47.03%), greater than MediciNova, Inc. (-20.70%), greater than Pharvaris N.V. (-38.27%), greater than PepGen Inc. (-60.17%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Molecular Partners AG (-39.16%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Rallybio Corporation (-77.39%), less than Opthea Limited (360.15%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), less than Entrada Therapeutics, Inc. (16.11%), greater than Vigil Neuroscience, Inc. (-83.89%),
| Company | ROE | Market cap |
|---|---|---|
| -47.03% | $342.68M | |
| -20.70% | $104.47M | |
| -38.27% | $1.20B | |
| -60.17% | $143.75M | |
| -184.40% | $37.86M | |
| -47.95% | $202.87M | |
| -39.16% | $216.81M | |
| -55.92% | $621.09M | |
| -26.83% | $3.05B | |
| -77.39% | $42.32M | |
| 360.15% | $486.27M | |
| -62.68% | $521.60M | |
| 16.11% | $703.50M | |
| -83.89% | $130.41M |
Build a custom stock screener for PMV Pharmaceuticals, Inc. (PMVP) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PMV Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PMV Pharmaceuticals, Inc. (PMVP) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PMV Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is PMV Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for PMV Pharmaceuticals, Inc. (PMVP)?
What is the highest ROE for PMV Pharmaceuticals, Inc. (PMVP)?
What is the 3-year average ROE for PMV Pharmaceuticals, Inc. (PMVP)?
What is the 5-year average ROE for PMV Pharmaceuticals, Inc. (PMVP)?
How does the current ROE for PMV Pharmaceuticals, Inc. (PMVP) compare to its historical average?